CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week

JOURNAL: Article Link

南京市第一医院心血管内科为多名复杂性肺高压患者实施肺血管介入治疗

qiaomingyue Keywords: 近年来,肺动脉高压在病理机制、诊断、风险评估及治疗等方面有诸多新进展,治疗策略不断更新,交感神经学说在肺动脉高压发生及发展中起着重要作用。经皮肺动脉去神经术(percutaneous pulmonary artery denervation,PADN)由陈绍良教授创新发明并成功开展后,越来越多的研究证据均显示其良好的疗效及广阔的前景,随着这一技术在全球的普及,肺动脉高压的治疗已经迈入在靶向药物治疗基础上的介入治疗新时代。

网站资料更新中...